This is a summary of the European public assessment report (EPAR) for Abasaglar. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Abasaglar. For practical information about using Abasaglar, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
Therapeutic Area (MeSH)
ATC Code
A10AE04
ATC Item
insulin glargine
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| insulin glargine | N/A | 甘精胰岛素 |
EMA Name
Abasaglar (previously Abasria)
Medicine Name
Abasaglar (previously Abasria)
Aliases
N/A
